FDG PET/CT Imaging After Just One Week May Predict Treatment Response in Patients With Advanced Melanoma
Following a single dose of pembrolizumab, FDG PET/CT scans were able to show metabolic changes in tumors that correlated...
Search/Filter
Loading...
Patients With Metastatic Colorectal Cancer May Continue Benefitting From Immunotherapy After Treatment Discontinuation
PHILADELPHIA – The majority of patients with metastatic colorectal cancer whose cancer did not progress during initial treatment with...
More Than 10% of Samples From a Stool-based Colorectal Cancer Test May Be Unsatisfactory
Fewer than half of patients with unsatisfactory samples from fecal immunochemical tests completed follow-up testing within 15 months PHILADELPHIA...
Nearly Half of Oncology Drugs Approved Since 1998 Are Precision Therapies
Cancer patients eligible for precision oncology therapies nearly doubled between 2017 and 2022 PHILADELPHIA – Of the 198 new...
Intravenous Immunoglobulin May Prevent Severe Infections Associated with Anti-BCMA Therapy for Multiple Myeloma
PHILADELPHIA – Intravenous immunoglobulin (IVIg) reduced the risk of severe infections by 90% in patients with multiple myeloma undergoing...
A Dendritic Cell Vaccine Was Safe and Induced Immune Responses in Patients With Multiple Myeloma
Vaccination given in combination with autologous stem cell transplant was associated with long-term disease control PHILADELPHIA – A dendritic...
Engaging in Administrative Payment Tasks May Correlate With Treatment Delays and Nonadherence in Cancer Care
PHILADELPHIA – Engaging in administrative tasks to estimate costs or pay for care among a cohort of cancer patients...
Lorazepam Treatment May Be Linked to Worse Outcomes for Pancreatic Cancer Patients
PHILADELPHIA – Patients with pancreatic cancer who took the benzodiazepine lorazepam (Ativan), commonly prescribed to treat anxiety during cancer...
Electrical Signals Between Skin Cells May Influence Melanoma Initiation
PHILADELPHIA – The transfer of a neurotransmitter from one type of skin cell to another (melanocytes to keratinocytes) altered...
AACR Journal Highlights Industry and Regulatory Perspectives on Improving Diversity in Clinical Trials
Article provides timely information following new law that will require trial sponsors to submit Diversity Action Plans to FDA...